Skip to main content
Premium Trial:

Request an Annual Quote

BCW Index Firms Unveil New Instruments, Software at ASMS

This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
Agilent Technologies and Thermo Fisher Scientific were the most active BCW Index firms releasing new products at this year’s American Society for Mass Spectrometry conference, held this week in Indianapolis.
Agilent said that it had made a number of enhancements to its 6100 Series single quadrupole mass spectrometers including faster negative/positive mode switching and improved injection-to-injection cycle time.
The 6100 Series mass spectrometers, two aimed at the high end of the market and two at the low end, were launched at last year’s ASMS conference in Seattle (see BioCommerce Week 5/31/2006). They are an integral part of Agilent’s plans to double its share in the estimated $1.3 billion mass spectrometry market by 2008.
“We believe, generally, there are always advancements that can be done in the platforms themselves,” John Sjeldsted, Agilent’s senior R&D manager for LC/MS, told BioCommerce Week in an interview last week. “We’re moving across the application space by adding things like metabolite ID, adding the compliance software, increasing the footprint of things like the GeneSpring into supporting triple quad data, and so on and so forth.”
Meanwhile, Thermo Fisher unveiled new versions of its LTQ Orbitrap instruments. The new instruments provide enhancements over the initial version of the Orbitrap, which was launched two years ago, with one iteration focused specifically on biomarker discovery.
Following the launch of the high-end Synapt HDMS at last year’s ASMS conference, Waters this year unveiled a new HDMS system paired with MALDI.
Click here for a table providing a synopsis of the product introductions at this year’s ASMS meeting.

File Attachments
The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.